[1]
Abrishami, M. et al. 2019. Refractive and Biometric Outcomes Following a Single Dose Intravitreal Bevacizumab Administration: To evaluate the effect of intravitreal bevacizumab monotherapy on refractive and biometric parameters. Journal of Ophthalmic and Optometric Sciences. 3, 2 (Apr. 2019), 16–20. DOI:https://doi.org/10.22037/joos.v3i2.32759.